Literature DB >> 10512061

Therapeutic range of digoxin's efficacy in heart failure: what is the evidence?

S G Terra1, J B Washam, G D Dunham, W A Gattis.   

Abstract

Clinical studies have solidified the utility of digoxin in patients with left ventricular dysfunction and normal sinus rhythm. No definitive data have been published to clarify the range of serum digoxin concentrations associated with clinical benefit. The traditional therapeutic range of 0.8-2.0 ng/ml was developed originally to classify digoxin toxicity, not efficacy. In addition, this reference range was used before publication of the Digitalis Investigators Group trial. Clinical and neurohormonal studies have attempted to characterize serum concentrations that are associated with clinical efficacy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10512061     DOI: 10.1592/phco.19.15.1123.30570

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  4 in total

1.  Therapeutic ranges of serum digoxin concentrations in patients with heart failure.

Authors:  Zachary D Goldberger; Ary L Goldberger
Journal:  Am J Cardiol       Date:  2012-04-11       Impact factor: 2.778

2.  Effect of lacosamide on the steady-state pharmacokinetics of digoxin: results from a phase I, multiple-dose, double-blind, randomised, placebo-controlled, crossover trial.

Authors:  Willi Cawello; Christa Mueller-Voessing; Jens-Otto Andreas
Journal:  Clin Drug Investig       Date:  2014-05       Impact factor: 2.859

3.  Erythrofordins D and E, two new cassaine-type diterpenes from Erythrophleum suaveolens.

Authors:  Tanja Grkovic; Jason R Evans; Rhone K Akee; Liang Guo; Myrtle Davis; Johnson Jato; Paul G Grothaus; Michelle Ahalt-Gottholm; Melinda Hollingshead; Jerry M Collins; David J Newman; Barry R O'Keefe
Journal:  Bioorg Med Chem Lett       Date:  2018-12-10       Impact factor: 2.823

4.  Bioluminescent sensor proteins for point-of-care therapeutic drug monitoring.

Authors:  Rudolf Griss; Alberto Schena; Luc Reymond; Luc Patiny; Dominique Werner; Christine E Tinberg; David Baker; Kai Johnsson
Journal:  Nat Chem Biol       Date:  2014-06-08       Impact factor: 15.040

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.